: The pause in Johnson & Johnson’s COVID-19 vaccine trial justifies why Big Pharma isn’t eager to rush to market

Pharmaceutical companies will resist pressure from politicians such as U.S. President Donald Trump to speed up the vaccine trial and approval process.